Brought to you by 
Rules-Based Medicine acquires Satoris assets
06 Jun 2011
Executive Summary
Just weeks ahead of closing its acquisition by Myriad Genetics Inc., Rules-Based Medicine Inc. (RBM; biomarker testing and diagnostics) has purchased all of the intellectual property assets of privately held Satoris Inc., which is developing an Alzheimer’s diagnostic.
Deal Industry
- In Vitro Diagnostics
- Services
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Rules-Based Medicine acquires Satoris assets
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice